Prince Martin J, Acosta Daisy, Guerra Mariella, Huang Yueqin, Jimenez-Velazquez Ivonne Z, Llibre Rodriguez Juan J, Salas Aquiles, Sosa Ana Luisa, Chua Kia-Chong, Dewey Michael E, Liu Zhaorui, Mayston Rosie, Valhuerdi Adolfo
Health Service and Population Research Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
Internal Medicine Department, Geriatric Section, Universidad Nacional Pedro Henriquez Ureña (UNPHU), Santo Domingo, Dominican Republic.
PLoS One. 2018 Feb 28;13(2):e0192889. doi: 10.1371/journal.pone.0192889. eCollection 2018.
Exposure to endogenous estrogen may protect against dementia, but evidence remains equivocal. Such effects may be assessed more precisely in settings where exogenous estrogen administration is rare. We aimed to determine whether reproductive period (menarche to menopause), and other indicators of endogenous estrogen exposure are inversely associated with dementia incidence.
Population-based cohort studies of women aged 65 years and over in urban sites in Cuba, Dominican Republic, Puerto Rico and Venezuela, and rural and urban sites in Peru, Mexico and China. Sociodemographic and risk factor questionnaires were administered to all participants, including ages at menarche, birth of first child, and menopause, and parity, with ascertainment of incident 10/66 dementia, and mortality, three to five years later.
9,428 women participated at baseline, with 72-98% responding by site. The 'at risk' cohort comprised 8,466 dementia-free women. Mean age varied from 72.0 to 75.4 years, lower in rural than urban sites and in China than in Latin America. Mean parity was 4.1 (2.4-7.2 by site), generally higher in rural than urban sites. 6,854 women with baseline reproductive period data were followed up for 26,463 person years. There were 692 cases of incident dementia, and 895 dementia free deaths. Pooled meta-analysed fixed effects, per year, for reproductive period (Adjusted Sub-Hazard Ratio [ASHR] 1.001, 95% CI 0.988-1.015) did not support any association with dementia incidence, with no evidence for effect modification by APOE genotype. No association was observed between incident dementia and; ages at menarche, birth of first child, and menopause: nulliparity; or index of cumulative endogenous estrogen exposure. Greater parity was positively associated with incident dementia (ASHR 1.030, 95% CI 1.002-1.059, I2 = 0.0%).
We found no evidence to support the theory that natural variation in cumulative exposure to endogenous oestrogens across the reproductive period influences dementia incidence in late life.
内源性雌激素的暴露可能对痴呆症具有保护作用,但证据仍不明确。在外源性雌激素使用较少的情况下,可能会更精确地评估此类影响。我们旨在确定生育期(月经初潮至绝经)以及内源性雌激素暴露的其他指标是否与痴呆症发病率呈负相关。
对古巴、多米尼加共和国、波多黎各和委内瑞拉城市地区,以及秘鲁、墨西哥和中国农村及城市地区65岁及以上女性进行基于人群的队列研究。向所有参与者发放社会人口统计学和风险因素调查问卷,包括月经初潮年龄、第一个孩子出生时的年龄、绝经年龄以及产次,并确定10/66痴呆症的发病情况以及三到五年后的死亡率。
9428名女性参与了基线调查,各地点的应答率为72%-98%。“风险”队列包括8466名无痴呆症的女性。平均年龄在72.0至75.4岁之间,农村地区低于城市地区,中国低于拉丁美洲。平均产次为4.1(各地点为2.4-7.2),农村地区普遍高于城市地区。对6854名有基线生育期数据的女性进行了26463人年的随访。有692例痴呆症发病病例,895例无痴呆症死亡病例。生育期每年汇总的荟萃分析固定效应(调整后的亚风险比[ASHR]为1.001,95%可信区间为0.988-1.015)不支持与痴呆症发病率存在任何关联,且没有证据表明APOE基因型会产生效应修饰作用。未观察到痴呆症发病与月经初潮年龄、第一个孩子出生时的年龄、绝经年龄、未生育或累积内源性雌激素暴露指数之间存在关联。较高的产次与痴呆症发病呈正相关(ASHR为1.030,95%可信区间为1.002-1.059,I2 = 0.0%)。
我们没有发现证据支持以下理论,即整个生育期内累积内源性雌激素暴露的自然变化会影响晚年痴呆症的发病率。